Establishment Labs Holdings Hits New 52-Week High of $94.49

Establishment Labs Holdings, Inc. has reached a significant milestone by hitting a new 52-week high of USD 94.49 on July 20, 2026. This achievement marks a remarkable performance over the past year, with the stock appreciating by 92.74%, significantly outpacing the S&P 500's growth of 18.21% during the same period. As a small-cap company in the Pharmaceuticals & Biotechnology sector, Establishment Labs Holdings, Inc. has a market capitalization of USD 1,644 million. Despite its recent stock performance, the company remains in a loss-making position, reflected in its price-to-earnings ratio, which is not applicable. The company does not offer a dividend, and its debt-to-equity ratio stands at 7.90, indicating a relatively high level of debt compared to equity. The stock's previous 52-week low was recorded at USD 33.35, highlighting the significant upward movement in its price. This milestone underscores the company's current market position and performance indicators within the competitive landscape of the pharmaceuticals and biotechnology industry.